Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CorVet is a veterinary postbiotic supplement developed by Sirius Pet Biologics for digestive health in dogs and cats. [2, 3] Marketed under the brand name FURMENT, CorVet is formulated using the company's proprietary Miiiome Technology. [4] Its mechanism of action involves modulating the pet's gut microbiome to support digestive functions and enhance immune health. [2, 3] The product is available as an oral gel and contains a proprietary blend of fermented Lactobacillus products, which are the postbiotics from species including L. acidophilus, L. paracasei, L. plantarum, L. reuteri, and L. rhamnosus. [2] A variation, CorVet Plus Gel, includes kaolin to provide a fast-acting remedy for conditions like food poisoning and diarrhea by absorbing toxins in the gut. [2, 11] The company has also noted positive outcomes in using the product to aid pets with inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and certain viral infections. [6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CorVet.